{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T01:35:35Z","timestamp":1776994535105,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017958","name":"Hubei Provincial Health Commission","doi-asserted-by":"crossref","award":["WJ2023F017"],"award-info":[{"award-number":["WJ2023F017"]}],"id":[{"id":"10.13039\/100017958","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-14368-7","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:23:51Z","timestamp":1773768231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of availability and affordability of lung cancer drugs in Central China: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Suyu","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"14368_CR1","doi-asserted-by":"crossref","unstructured":"Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lance. 2017;390(10100):1211\u201359.","DOI":"10.1016\/S0140-6736(17)32154-2"},{"issue":"3","key":"14368_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"9856","key":"14368_CR3","first-page":"1840","volume":"380","author":"I Soerjomataram","year":"2012","unstructured":"Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012;380(9856):1840\u201350.","journal-title":"\u6682\u65e0\u6570\u636e"},{"issue":"10","key":"14368_CR4","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.jtho.2020.04.028","volume":"15","author":"S Gao","year":"2020","unstructured":"Gao S, Li N, Wang S, Zhang F, Wei W, Li N, Bi N, Wang Z, He J. Lung Cancer in People\u2019s Republic of China. J Thorac Oncol. 2020;15(10):1567\u201376.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"14368_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nrclinonc.2017.31","volume":"14","author":"V Prasad","year":"2017","unstructured":"Prasad V, De Jes\u00fas K, Mailankody S. The high price of anticancer drugs: origins, implications, barriers, solutions. Nat Rev Clin Oncol. 2017;14(6):381\u201390.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"14368_CR6","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s11255-023-03653-7","volume":"55","author":"J Guzman-Esquivel","year":"2023","unstructured":"Guzman-Esquivel J, Murillo-Zamora E, Ortiz-Mesina M, Galvan-Salazar HR, De-Leon-Zaragoza L, Casarez-Price JC, Delgado-Enciso J, Delgado-Enciso I. Regional and national burden of prostate cancer: incidence, mortality, years of life lost, and disability-adjusted life years, in Mexico and Latin America from 1990 to 2019. Int Urol Nephrol. 2023;55(9):2155\u201360.","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"14368_CR7","first-page":"e077089","volume":"14","author":"W Li","year":"2024","unstructured":"Li W, Lu W, Chen H, Zhang C, Wang M, Zheng F, Wu HH, Wan GW, Yang Q, Ye L. Access to innovative anticancer medicines in China: a national survey on availability, price and affordability. BMJ Open. 2024;14(4):e077089.","journal-title":"\u6682\u65e0\u6570\u636e"},{"issue":"11","key":"14368_CR8","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.annonc.2020.09.002","volume":"31","author":"N Cherny","year":"2020","unstructured":"Cherny N, Sullivan R, Torode J, Saar M, Eniu A. ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe (27, pg 1423, 2016). Ann Oncol. 2020;31(11):1589\u20131589.","journal-title":"Ann Oncol"},{"issue":"1","key":"14368_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12939-018-0870-5","volume":"17","author":"X Guan","year":"2018","unstructured":"Guan X, Hu H, Man C, Shi L. A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals. Int J Equity Health. 2018;17(1):158.","journal-title":"Int J Equity Health"},{"key":"14368_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12913-015-1008-8","volume":"15","author":"X Xi","year":"2015","unstructured":"Xi X, Li W, Li J, Zhu X, Fu C, Wei X, Chu S. A survey of the availability, prices and affordability of essential medicines in Jiangsu Province, China. BMC Health Serv Res. 2015;15:345.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"14368_CR11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/tmi.13559","volume":"26","author":"YL Zhu","year":"2021","unstructured":"Zhu YL, Xu XL, Fang WQ, Wang Y, Dai HZ, Li X. Availability, cost and affordability of selected antibiotics and antiviral medicines against infectious diseases from 2013 to 2019 in Nanjing, China. Trop Med Int Health. 2021;26(5):518\u201329.","journal-title":"Trop Med Int Health"},{"key":"14368_CR12","doi-asserted-by":"crossref","unstructured":"Liu CX, Zhang XP, Liu CJ, Ewen M, Zhang ZN, Liu GQ. Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China. BMC Health Serv Res. 2017:17.","DOI":"10.1186\/s12913-017-2553-0"},{"issue":"2","key":"14368_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/hpm.2963","volume":"35","author":"RX Xu","year":"2020","unstructured":"Xu RX, Li ST, Lv XW, Xie XF. Prices, availability, and affordability of national essential medicines in public primary hospitals: A cross-sectional survey in poverty-stricken rural areas in China. Int J Health Plan M. 2020;35(2):545\u201357.","journal-title":"Int J Health Plan M"},{"key":"14368_CR14","unstructured":"The 2023 Statistical Bulletin of the People\u2019s Republic of China on National Economic. and Social Development. https:\/\/www.stats.gov.cn\/sj\/zxfb\/202402\/t20240228_1947915.html."},{"key":"14368_CR15","unstructured":"Prices MM, Availability, Affordability, and, Components P. https:\/\/www.haiweb.org\/medicineprices\/manual\/documents.html."},{"issue":"5","key":"14368_CR16","first-page":"373","volume":"7","author":"RR Brookman","year":"1986","unstructured":"Brookman RR. Aids - Etiology, Diagnosis, Treatment and Prevention - Devita,Vt, Hellman,S, Rosenberg,Sa. J Adolesc Health. 1986;7(5):373\u2013373.","journal-title":"J Adolesc Health"},{"issue":"10013","key":"14368_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(15)00469-9","volume":"387","author":"R Khatib","year":"2016","unstructured":"Khatib R, Mckee M, Shannon H, Chow C, Rangarajan S, Teo K, Wei L, Mony P, Mohan V, Gupta R, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet (London England). 2016;387(10013):61\u20139.","journal-title":"Lancet (London England)"},{"key":"14368_CR18","unstructured":"Notice on Adjusting the Minimum Wage Standards for. 2022 [https:\/\/rst.hunan.gov.cn\/rst\/xxgk\/zcfg\/zxzc\/202203\/29022168\/files\/48f5ca44e71e489c8d032bce65a3f00b.pdf]"},{"issue":"1","key":"14368_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12913-016-1735-5","volume":"16","author":"X Liu","year":"2016","unstructured":"Liu X, Sun X, Zhao Y, Meng Q. Financial protection of rural health insurance for patients with hypertension and diabetes: repeated cross-sectional surveys in rural China. BMC Health Serv Res. 2016;16(1):481.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"14368_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12885-017-3980-3","volume":"18","author":"MR Sarwar","year":"2018","unstructured":"Sarwar MR, Iftikhar S, Saqib A. Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan. BMC Cancer. 2018;18(1):14.","journal-title":"BMC Cancer"},{"key":"14368_CR21","doi-asserted-by":"publisher","first-page":"628744","DOI":"10.3389\/fpubh.2021.628744","volume":"9","author":"P Ocran Mattila","year":"2021","unstructured":"Ocran Mattila P, Ahmad R, Hasan SS, Babar ZU. Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature. Front Public Health. 2021;9:628744.","journal-title":"Front Public Health"},{"issue":"8","key":"14368_CR22","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/annonc\/mdw213","volume":"27","author":"N Cherny","year":"2016","unstructured":"Cherny N, Sullivan R, Torode J, Saar M, Eniu A. ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe. Ann Oncol. 2016;27(8):1423\u201343.","journal-title":"Ann Oncol"},{"issue":"1","key":"14368_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1186\/s12913-023-09706-y","volume":"23","author":"C Rurangwa","year":"2023","unstructured":"Rurangwa C, Ndayisenga J, Sezirahiga J, Nyirimigabo E. Availability and affordability of anticancer medicines at cancer treating hospitals in Rwanda. BMC Health Serv Res. 2023;23(1):717.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"14368_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bpg.2014.02.008","volume":"28","author":"HJ Ehni","year":"2014","unstructured":"Ehni HJ. Expensive cancer drugs and just health care. Best Pract Res Clin Gastroenterol. 2014;28(2):327\u201337.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"14368_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/2224-3151.239415","volume":"7","author":"MV Chivukula","year":"2018","unstructured":"Chivukula MV, Tisocki K. Approaches to improving access to essential cancer medicines in the WHO South-East Asia Region. WHO South East Asia J Public Health. 2018;7(2):62\u20136.","journal-title":"WHO South East Asia J Public Health"},{"issue":"12","key":"14368_CR26","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.healthpol.2020.09.001","volume":"124","author":"S Vogler","year":"2020","unstructured":"Vogler S, Fischer S. How to address medicines shortages: Findings from a cross-sectional study of 24 countries. Health Policy. 2020;124(12):1287\u201396.","journal-title":"Health Policy"},{"issue":"42","key":"14368_CR27","doi-asserted-by":"publisher","first-page":"71548","DOI":"10.18632\/oncotarget.17742","volume":"8","author":"DA Goldstein","year":"2017","unstructured":"Goldstein DA, Clark J, Tu Y, Zhang J, Fang F, Goldstein R, Stemmer SM, Rosenbaum E. A global comparison of the cost of patented cancer drugs in relation to global differences in wealth. Oncotarget. 2017;8(42):71548\u201355.","journal-title":"Oncotarget"},{"issue":"1","key":"14368_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2471\/BLT.24.291640","volume":"103","author":"L Bai","year":"2025","unstructured":"Bai L, Huang T, Li H, Shi L, Denburg A, Gupta S, Guan X. Medicine availability and affordability for paediatric cancers, China. Bull World Health Organ. 2025;103(1):19\u2013B31.","journal-title":"Bull World Health Organ"},{"issue":"3","key":"14368_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2471\/BLT.08.053645","volume":"87","author":"J Robertson","year":"2009","unstructured":"Robertson J, Forte G, Trapsida JM, Hill S. What essential medicines for children are on the shelf? Bull World Health Organ. 2009;87(3):231\u20137.","journal-title":"Bull World Health Organ"},{"issue":"6","key":"14368_CR30","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.xphs.2019.01.012","volume":"108","author":"X Guan","year":"2019","unstructured":"Guan X, Zhang J, Man C, Ni B, Shi L. How Far Have We Come? Challenges to Orphan Drug Access in China, 2011\u20132017. J Pharm Sci. 2019;108(6):2199\u2013205.","journal-title":"J Pharm Sci"},{"issue":"4","key":"14368_CR31","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1016\/S2214-109X(13)70072-X","volume":"1","author":"Y Fang","year":"2013","unstructured":"Fang Y, Wagner AK, Yang S, Jiang M, Zhang F, Ross-Degnan D. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China. Lancet Glob Health. 2013;1(4):e227\u2013237.","journal-title":"Lancet Glob Health"},{"issue":"8","key":"14368_CR32","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1097\/JTO.0b013e3181e7c425","volume":"5","author":"PA Learn","year":"2010","unstructured":"Learn PA, Bach PB. Pem and the cost of multicycle maintenance. J Thorac Oncol. 2010;5(8):1111\u20132.","journal-title":"J Thorac Oncol"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14368-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14368-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14368-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:55:17Z","timestamp":1776992117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14368-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14368"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14368-7","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the institutional review board of Medical Ethics Committee, Zhongnan Hospital of Wuhan University before data collection, and informed consent was secured from all participants before their involvement. The study adhered to the Declaration of Helsinki to this effect (Ethical approval Study ID:2023016\u00a0K).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"575"}}